Predicting Individual Survival after Curative Esophagectomy for Squamous Cell Carcinoma of Esophageal
Table 1
Clinical, epidemiological, and pathological feature.
Median/
IQR/percentage
Age, year
62
56-67
Sex
Male
411
81.7%
Female
92
18.3%
BMI, kg/m2
22.23
20.07-24.19
Tobacco use
No
338
67.2%
Yes
165
32.8%
Alcohol use
No
381
75.7%
Yes
122
24.3%
Comorbidities
History of hypertension
No
330
65.6%
Yes
173
34.4%
History of diabetes
No
381
75.7%
Yes
122
24.3%
History of COPD
No
445
88.5%
Yes
58
11.5%
History of hepatitis
No
428
85.1%
Yes
75
14.9%
History of cardiovascular disease
No
422
83.9%
Yes
81
16.1%
Preoperative albumin, g/L
41.00
39.00-43.00
Preoperative platelet, 109
194.00
157.00-239.00
Preoperative WBC, 109
5.88
4.89-7.23
Preoperative NLR
2.25
1.67-3.17
Length of tumor, cm
3.00
2.00-4.50
Location of tumor
Upper
82
16.3%
Middle
302
60.0%
Lower
119
23.7%
Differentiation of tumor
Well
65
12.9%
Moderate
299
59.4%
Poor
139
27.6%
Pathological T stage
T1
73
14.5%
T2
146
29.0%
T3
242
48.1%
T4
42
8.3%
Pathological N factor
N0
263
52.3%
N1
140
27.8%
N2
70
13.9%
N3
30
6.0%
Pathological stage
I
72
14.3%
II
227
45.1%
III
135
26.8%
IV
69
13.7%
Number of dissected LNs
13
8-19
Number of positive LNs
0
0-2
Rate of positive LNs
0
0-0.17
Postoperative complications
Postoperative pulmonary complications
148
29.4%
Postoperative anastomotic leakage
29
5.8%
Postoperative cardiovascular disease
107
21.3%
Sepsis
34
6.8%
Data are expressed as median (interquartile range, IQR), (percentage, %). BMI: body mass index; COPD: chronic obstructive pulmonary disease; NLR: neutrophil to lymphocyte ratio.
